ClinicalTrials.gov
public full text
Public Domain
Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis
The investigators reasoned that a hypertonic saline concentration higher than 3% could be safe and more efficacious in the treatment of bronchiolitis, alleviating severe symptoms and preventing the need for hospitalization in some instances.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis#917652
- The Effectiveness of Nebulized Hypertonic Saline Solution for Acute Bronchiolitis#857793
- Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis#826019
- Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis#833580
- Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis#831844
Record · ID 869747
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive